External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ECP 2021

-
Coming soon
08:15 AM
Duration 10mins Virtual
Development of an optimised diagnostic algorithm using multiplex immunochemistry (IHC) for excluding diagnosis of carcinoma-of-unknown-primary-origin, based on experience from the Phase II CUPISCO trial
Pauli C, Guiu XM, Chenard MP, Banks P, Chalabi N,Erb G, Toro P, Moch H

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar